| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | B02AB04 |
| UNII: | 0FD207WKDU |
| InChI Key | XASIMHXSUQUHLV-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C20H22N4O5 |
| Molecular Weight | 398.42 |
| AlogP | 1.39 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 7.0 |
| Polar Surface Area | 134.81 |
| Molecular species | BASE |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 29.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Protease
Serine protease
Serine protease PA clan
Serine protease S1A subfamily
|
- | 32000 | - | - | 90-100 | |
|
Enzyme
Protease
Serine protease
|
1000 | 29 | - | - | 90-100 | |
|
Enzyme
|
1000 | 29 | - | - | 90-100 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC22 family of organic cation and anion transporters
|
- | 16500 | - | - | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC47 family of multidrug and toxin extrusion transporters
|
- | 12700 | - | - | 77 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 135632 |
| ChEMBL | CHEMBL590799 |
| DrugBank | DB13729 |
| DrugCentral | 471 |
| EPA CompTox | DTXSID6044010 |
| FDA SRS | 0FD207WKDU |
| Guide to Pharmacology | 6432 |
| PubChem | 2536 |
| SureChEMBL | SCHEMBL125269 |
| ZINC | ZINC000003871842 |